Life Technologies Corp (LIFE): Today's Featured Drugs Winner

Life Technologies (LIFE) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day down 0.4%. By the end of trading, Life Technologies rose 46 cents (1.1%) to $42.01 on heavy volume. Throughout the day, 2.5 million shares of Life Technologies exchanged hands as compared to its average daily volume of 1.4 million shares. The stock ranged in a price between $41.90-$42.81 after having opened the day at $42.01 as compared to the previous trading day's close of $41.55. Other companies within the Drugs industry that increased today were: Cormedix (CRMD), up 32.5%, China Pharma (CPHI), up 18.9%, ImmuCell Corporation (ICCC), up 15.4%, and Bacterin International Holdings (BONE), up 13.3%.

Life Technologies Corporation operates as a global life sciences company. Life Technologies has a market cap of $7.34 billion and is part of the health care sector. The company has a P/E ratio of 18.1, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 5.6% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Life Technologies a buy, no analysts rate it a sell, and six rate it a hold.

TheStreet Ratings rates Life Technologies as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, attractive valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

• You can view the full Life Ratings Report.

On the negative front, Complete Genomics (GNOM), down 10.8%, XenoPort (XNPT), down 9.6%, Rosetta Genomics (ROSG), down 9.5%, and Prima Biomed Ltd. ADR (PBMD), down 9.1%, were all losers within the drugs industry with Biogen Idec (BIIB) being today's drugs industry loser.

• Use our drugs section to find industry-relevant news.
• Or find some new ideas from our top rated stocks lists.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF (XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech (BIS).

• Find other investment ideas from our top rated ETFs lists.

 

For more information on Life Technologies Corp click any of the following:

• Life Technologies Corp Stock Price

• Life Technologies Corp Analyst Ratings

• Life Technologies Corp Key Stats & Profile

• Life Technologies Corp Earnings

• Life Technologies Corp Ratio Comparison

• Life Technologies Corp Growth Rates

• Life Technologies Corp Balance Sheet

• Life Technologies Corp Cash Flow

• Life Technologies Corp Income Statement